Topical tacrolimus in alopecia areata.

Eleven patients with alopecia areata affecting 10% to 75% of the scalp, average duration 6 years, had no terminal hair growth in response to tacrolimus ointment 0.1% applied twice daily for 24 weeks. Treatment failure may reflect insufficient depth of penetration of the ointment formulation and less than optimal patient selection.
AuthorsVera H Price, Andrea Willey, Bryan K Chen
JournalJournal of the American Academy of Dermatology (J Am Acad Dermatol) Vol. 52 Issue 1 Pg. 138-9 (Jan 2005) ISSN: 1097-6787 [Electronic] United States
PMID15627095 (Publication Type: Clinical Trial, Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Immunosuppressive Agents
  • Ointments
  • Tacrolimus
  • Administration, Topical
  • Adolescent
  • Adult
  • Alopecia Areata (drug therapy)
  • Female
  • Humans
  • Immunosuppressive Agents (administration & dosage)
  • Male
  • Middle Aged
  • Ointments
  • Tacrolimus (administration & dosage)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!

Choose Username:
Verify Password: